Bio-Techne Corporation TECH NASDAQ

Bio-Techne Corporation (TECH) generated $82.41M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $5.92M, free cash flow was $76.49M.

Free cash flow margin was 25.9% of revenue. Cash conversion ratio was 2.17x, indicating earnings are backed by cash.

The company returned $12.47M in dividends and $24K in share buybacks to shareholders during the quarter.

Criteria supported by this page:

• HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
• MOAT (65/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (45/100) — Cash conversion ratio was 2.17x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 64/100 with 3/7 criteria passed.